ArticleCost effectiveness and resource allocation : C/E2015

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components.

Panagiotis Stafylas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.